isothiuronium has been researched along with Ventricular Dysfunction, Left in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Larson, DF; Watson, RR; Yang, B | 1 |
| Cutini, GJ; Paigel, AS; Pinto, VD; Sartório, CL; Stefanon, I; Vassallo, DV | 1 |
2 other study(ies) available for isothiuronium and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Modulation of iNOS activity in age-related cardiac dysfunction.
Topics: Aging; Animals; Arginine; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescent Antibody Technique, Indirect; Guanidines; Isothiuronium; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; RNA, Messenger; Ventricular Dysfunction, Left | 2004 |
Enhanced beta-adrenergic response in rat papillary muscle by inhibition of inducible nitric oxide synthase after myocardial infarction.
Topics: Adrenergic beta-Agonists; Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoproterenol; Isothiuronium; Male; Myocardial Contraction; Myocardial Infarction; Nitric Oxide Synthase Type II; Papillary Muscles; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Ventricular Dysfunction, Left | 2007 |